Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Propanc Biopharma, Inc. PPCB

Set alert

Price alert · PPCB

All alert types
1.84 USD -0.27 -12.80%

At close · Oct 30

1.89 +0.05 +2.51%

After hours · Oct 30, 7:06 PM ET

Bid
1.84 × 2
Ask
1.86 × 2
1.82 Day range 2.13
1.79 52-week range 315.00
YTD
-98.63%
1 year
-99.41%
Open
1.91
Prev close
2.11
Mkt cap
1.90M
Vol
65.61K
Avg vol
189.01K
EPS
-176.20
P/E
0.00
Div yield
0.00%
More statistics
Low
1.82
High
2.13
Earnings
Sep 27, 2023

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 26, 2026Split: 1 for 10
Signals (10)
NameDateAgo
RSI: OversoldOct 13, 20262 weeks ago
MACD: Buy SignalOct 6, 20263 weeks ago
MACD: Sell SignalSep 3, 20261 month ago
SMA: BearishSep 1, 20262 months ago
SMA: BearishAug 28, 20262 months ago
SMA: BullishAug 27, 20262 months ago
SMA: BullishAug 27, 20262 months ago
RSI: OverboughtAug 27, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
RSI: OversoldJul 31, 20263 months ago

Financial health

Altman Z-Score

-19.36 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -0.1×
FY 2017: -0.4×FY 2018: -0.2×FY 2019: -0.3×FY 2020: -12159×FY 2021: -0.1×FY 2022: -0.1×FY 2023: -0.1×FY 2024: -823654×FY 2025: -0.3×FY 2026: -0.1×
FY 2017 5y median -0.1× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 0.2×
FY 2017: -0.6×FY 2018: -0.2×FY 2019: -0.4×FY 2020: -15830×FY 2021: -0.1×FY 2022: -0.1×FY 2023: -0.1×FY 2024: -438835×FY 2025: 1.2×FY 2026: 0.2×
FY 2017 5y median -0.1× FY 2026
P/FCF -0.3×
FY 2017: -1.6×FY 2018: 0.0×FY 2019: -0.9×FY 2020: -31165×FY 2021: -0.1×FY 2022: -0.2×FY 2023: -0.2×FY 2024: -1773449×FY 2025: -40.6×FY 2026: -0.3×
FY 2017 5y median -0.3× FY 2026
EV/EBITDA -0.0×
FY 2017: -1.4×FY 2018: -1.3×FY 2019: -0.8×FY 2020: -18449×FY 2021: -0.5×FY 2022: -0.6×FY 2023: -0.3×FY 2024: -1313923×FY 2025: -0.3×FY 2026: -0.0×
FY 2017 5y median -0.3× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -337.1%
FY 2017: -63.2%FY 2018: 0.0%FY 2019: -109.2%FY 2020: -0.0%FY 2021: -730.5%FY 2022: -569.0%FY 2023: -470.8%FY 2024: -0.0%FY 2025: -2.5%FY 2026: -337.1%
FY 2017 5y median -337.1% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -200.6%
FY 2017: 144.6%FY 2018: 104.3%FY 2019: 133.9%FY 2020: 130.2%FY 2021: 66.0%FY 2022: 87.9%FY 2023: 85.4%FY 2024: 48.2%FY 2025: -423.7%FY 2026: -200.6%
FY 2017 5y median 48.2% FY 2026
ROIC -192.4%
FY 2017: 270.1%FY 2018: 175.4%FY 2019: 93.4%FY 2020: 158.8%FY 2021: 71.9%FY 2022: 98.4%FY 2023: 65.9%FY 2024: 50.7%FY 2025: -366.4%FY 2026: -192.4%
FY 2017 5y median 50.7% FY 2026
ROA -147.6%
FY 2017: -8275.0%FY 2018: -9860.3%FY 2019: -5664.4%FY 2020: -4812.3%FY 2021: -15464.5%FY 2022: -3255.4%FY 2023: -4410.2%FY 2024: -2515.8%FY 2025: -300.1%FY 2026: -147.6%
FY 2017 5y median -2515.8% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 68.3%
FY 2017: 16.8%FY 2018: 31.0%FY 2019: 34.0%FY 2020: -33.6%FY 2021: 48.1%FY 2022: -9.9%FY 2023: 10.8%FY 2024: 13.5%FY 2025: -3628.9%FY 2026: 68.3%
FY 2017 FY 2026
EPS (diluted) 95.3%
FY 2017: 53.6%FY 2018: 84.1%FY 2019: 93.9%FY 2020: 100.0%FY 2021: -248484.9%FY 2022: 93.8%FY 2023: 96.3%FY 2024: 100.0%FY 2025: -15679903.4%FY 2026: 95.3%
FY 2017 FY 2026
Free Cash Flow -1302.5%
FY 2017: 55.3%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 10.3%FY 2021: 38.1%FY 2022: -25.4%FY 2023: 23.0%FY 2024: 15.4%FY 2025: 56.7%FY 2026: -1302.5%
FY 2017 FY 2026

Financial Health

Current Ratio 2.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.5×FY 2026: 2.5×
FY 2017 5y median 0.0× FY 2026
Quick Ratio 2.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 1.5×FY 2026: 2.5×
FY 2017 5y median 0.0× FY 2026
Debt / Equity 0.0×
FY 2017: -0.6×FY 2018: -0.7×FY 2019: -0.4×FY 2020: -0.4×FY 2021: -0.2×FY 2022: -0.3×FY 2023: -0.2×FY 2024: -0.3×FY 2025: 0.1×FY 2026: 0.0×
FY 2017 5y median -0.2× FY 2026
Net Debt / EBITDA 0.0×
FY 2017: -0.7×FY 2018: -1.0×FY 2019: -0.3×FY 2020: -0.5×FY 2021: -0.4×FY 2022: -0.5×FY 2023: -0.2×FY 2024: -0.7×FY 2025: -0.0×FY 2026: 0.0×
FY 2017 5y median -0.2× FY 2026
Interest Coverage -42.2×
FY 2017: -1.8×FY 2018: -1.4×FY 2019: -2.0×FY 2020: -2.0×FY 2021: -4.0×FY 2022: -3.5×FY 2023: -3.3×FY 2024: -2.3×FY 2025: -102×FY 2026: -42.2×
FY 2017 5y median -3.5× FY 2026

Dividends

Dividend Yield 55.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 55.3%
FY 2017 5y median 0.0% FY 2026
Payout Ratio -4.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: -4.9%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30